Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name BRAEBURN PHARMACEUTICALS, INC Proposed Ticker BBRX CUSIP 10481L100 Business Description A commercial-stage pharmaceutical company focused on the development and commercialization of novel long-acting medications for serious disorders of the central nervous system, or CNS. Lead Underwriter BofA Merrill Lynch,J.P. Morgan Securities LLC Co-Managers Canaccord Genuity Inc,Deutsche Bank Securities Inc. Initial Shares 7,700,000 Revised Initial Shares 7,692,308 Initial Price $18.00-$21.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.